AllCereno Scientific FDA grants Cereno Scientific’s lead candidate Orphan Drug Designation Cereno Scientific is accelerating the building of a platform of drug candidates in epigenetic modulation,…dantetzlMarch 31, 2020
AllNexImmune NexImmune Expands Executive Team with Appointments of Chief Medical Officer and Chief Financial Officer GAITHERSBURG, MD -- January 08, 2020 – NexImmune, a clinical-stage biopharmaceutical company developing novel immune-therapeutics based…dantetzlJanuary 8, 2020
AllAsclepix Therapeutics AsclepiX Therapeutics, Inc. Expands Leadership Team with Appointment of Industry Leader Theresa Heah, MD, MBA as Chief Medical Officer BALTIMORE, MD – AsclepiX Therapeutics, Inc., a biopharmaceutical company that uses computational biology to identify…dantetzlJanuary 6, 2020
3DBio TherapeuticsAll 3DBio Therapeutics Receives FDA Rare Pediatric Disease Designation for AuriNovo™ for Ear Reconstruction in Microtia Patients NEW YORK, December 6, 2019 /PRNewswire/ — 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting for…dantetzlDecember 6, 2019
3DBio TherapeuticsAll 3DBio Therapeutics Announces Appointment of Sol Barer, Ph.D. and Kevin Slawin, M.D. to Board of Directors NEW YORK, April 2, 2019 /PRNewswire/ -- 3DBio Therapeutics, an emerging leader in the field of 3D-bioprinting…skylarbennethumApril 2, 2019